Board of Directors

Robert V. Gunderson, Jr.

Mr. Gunderson is a founding partner of Gunderson Dettmer, which has become the nation's leading business law firm for entrepreneurs, emerging growth companies and venture capitalists. He serves as principal outside counsel for many of the country's leading venture capital firms, public and private companies and investment banks. Bob is a nationally recognized authority in the areas of venture capital and emerging growth companies and has represented parties to many of Silicon Valley's most significant financings, IPOs, and mergers and acquisitions.

Mr. Gunderson is the co-editor of the Emerging Growth Companies Series of legal texts (GlasserLegalWorks) as well as the widely used, two-volume treatise, Venture Capital and Public Offering Negotiation (third edition), published by Aspen Law & Business. He is also co-author of Corporate Partnering: Structuring and Negotiating Domestic and International Strategic Alliances (Prentice Hall Law & Business 1992) as well as The Private Offering Handbook (Prentice Hall Law & Business 1990).

Mr. Gunderson currently serves on the Board of Directors of Theravance, Inc., a publicly traded biopharmaceutical company, as well as on the boards of several private companies. He also serves on the Ewing Marion Kauffman Foundation Advisory Board for the Berkeley Center for Law and Technology at the University of California, Berkeley.

Mr. Gunderson holds a J.D. degree from the University of Chicago, where he was Executive Editor of The University of Chicago Law Review. He received an M.B.A. in finance from The Wharton School, University of Pennsylvania and an M.A. from Stanford University. He is admitted to practice in California.

Ken Howery

Mr. Howery is a co-founder of PayPal and served as the company's first CFO. While at PayPal, Mr. Howery helped raise over $200 million in private financing, worked on the company's public offerings, and assisted in the company's $1.5 billion sale to eBay. Before launching Founders Fund, Mr. Howery was a member of the research and trading teams at Clarium Capital Management, as well as a partner with Peter Thiel in his private venture investing, helping Mr. Theil with diligence deals, including Mr. Theil's initial Facebook investment. Mr. Howery received his BA in Economics from Stanford University. He is also a member of the Council on Competitiveness and the Selection Committee of the World Economic Forum Technology Pioneers Program. In August 2010, VC Journal named Mr. Howery one of the Top 10 VCs Under 35.

Jeff Larson

Mr. Larson received a Bachelor of Arts degree in Economics from Macalester College (St. Paul, MN) in 1979. From 1979 through 1991 Mr. Larson was employed by Cargill, Incorporated in a variety of roles in agricultural and financial trading. From 1991 until 2004, Mr. Larson was a Senior Vice President and Portfolio Manager at Harvard Management Company, Inc., the endowment manager for Harvard University. In 2004 Mr. Larson founded Sowood Capital Management LP, a multi-strategy investment firm. Subsequent to the closure of Sowood in late 2007, Mr. Larson has been a principal investor and engaged in philanthropic activities. Mr. Larson is a member of the Board of Trustees of Macalester College and serves as Chair of its Investment Committee.

Wesley D. Sterman, M.D.

Dr. Sterman is a healthcare executive and investor, who has founded, directed, managed, and funded numerous companies. Prior to PharmacoFore, he was a founding director and investor of Theravance, Inc., which went public in late 2004. Before Theravance, Dr. Sterman founded and acted as CEO of Heartport, Inc., a manufacturer of less invasive cardiac surgery products, which was taken public in 1996. Heartport was acquired by Johnson & Johnson in 2001. Previously, Dr. Sterman was founder and CEO of EndoVascular Technologies, Inc. Following its IPO, the company was acquired by Guidant, Inc., which is now a division of Boston Scientific, Inc. Prior to that, he led the healthcare investment efforts at Menlo Ventures. During his tenure there, Gilead Sciences, now a $30 billion public biotechnology company, was incubated internally at Menlo Ventures. Dr. Sterman holds a California medical license and earned both M.D. and M.B.A. degrees from Stanford University. He currently serves as a voluntary instructor at the Stanford Graduate School of Business.